In this study, subjects were randomized to either nicotine replacement patches or ENDs device which used e nicotine liquid. In order to maintain the blind, subjects used both the nicotine replacement patches and the ENDS device. Subjects were requested not to smoke, but the number of regular cigarettes used were collected. Subject were seen every day for 15 days. The nicotine patch was applied at rotating sites, and the ENDS cartridge was replaced every day. The cartridge was weighed when dispensed and upon return. On days, 1, 5, 10 subjects remained in the clinic for 4 hours for collection of biomarkers. On these days, a new ENDS cartridge device was inserted and then used for 10 minutes, and then not used for 4 hours. A new cartridge was insert at the end of 4 hours. The patch was applied prior to using the ENDS device on these days.
The SU domain was used to represent the number of cigarettes used, but is not shown.
In this study, the weight of the contents in the cartridges were tracked. A Product Accountability (DA) domain was submitted to represent dispensed and returned weights of each cartridge. Only a few rows are shown. The produt accountability information was not provided for the nicotine replaement patches.
da.xpt
xx.xpt
Row
STUDYID
DOMAIN
USUBJID
DASEQ
DAREFID
DATESTCD
DATEST
DACAT
DASCAT
DAORRES
DAORRESU
DASTRESC
DASTRESN
DASTRESU
VISITNUM
DADTC
1
TEDP07
DA
10001
1
CRT8754
DISPAMT
Dispensed Amount
STUDY PRODUCT
E-LIQUID
25.3
g
25
25
g
1
2004-06-06
2
TEDP07
DA
10001
2
CRT8755
RETAMT
Returned Amount
STUDY PRODUCT
E-LIQUID
23
g
23
23
g
1
2020-06-06
3
TEDP07
DA
10001
3
CRT9756
DISPAMT
Dispensed Amount
STUDY PRODUCT
E-LIQUID
25.1
g
25
25
g
1
2020-06-07
4
TEDP07
DA
10001
4
CRT9757
RETAMT
Returned Amount
STUDY PRODUCT
E-LIQUID
10
g
14
143
g
2
2020-06-08
5
TEDP07
DA
10001
5
CRT8755
DISPAMT
Dispensed Amount
STUDY PRODUCT
E-LIQUID
25.2
g
25
25
g
2
2004-06-09
$warningHtml
EC was used to represent the collected exposure data since a double dummy design was used.,while the EX domain was used to represent the subject's exposure to the actual product containing nicotine. The sponsor represented each cartridge used. The dose was represented has "1" to indicate only one cartidge or patch wsa used. The actual date and time of usage of the cartridge was recorded precisely on days 1, 5, and 10, while only the date of usage was reccorded on other days.
$titleHtml
ec.xpt
Row
STUDYID
DOMAIN
USUBJID
ECSEQ
ECTRT
ECDOSE
ECDOSU
ECROUTE
ECFREQ
ECLOC
ECLAT
ECDIR
EPOCH
ECSTDTC
ECENDTC
1
TEDP07
EC
10001
1
ENDS
1
CARTRIDGE
INHALED
PRODUCT EXPOSURE
2020-06-01T08:00
2020-06-01T08:10
2
TEDP07
EC
10001
2
PATCH
1
PATCH
TRANSDERMAL
ARM
RIGHT
UPPER
PRODUCT EXPOSURE
2020-06-01
2020-06-02
3
TEDP07
EC
10001
3
ENDS
1
CARTRIDGE
INHALED
AD LIBITUM
PRODUCT EXPOSURE
2020-06-01T12:10
2020-06-02
4
TEDP07
EC
10001
1
ENDS
1
CARTRIDGE
INHALED
AD LIBITUM
PRODUCT EXPOSURE
2020-06-02
2020-06-02
5
TEDP07
EC
10001
1
PATCH
1
PATCH
TRANSDERMAL
ARM
LEFT
UPPER
PRODUCT EXPOSURE
2020-06-02
2020-06-03
6
TEDP07
EC
10001
2
ENDS
1
CARTRIDGE
INHALED
AD LIBITUM
PRODUCT EXPOSURE
2020-06-03
2020-06-03
7
TEDP07
EC
10001
3
PATCH
1
PATCH
TRANSDERMAL
LEG
LEFT
UPPER
PRODUCT EXPOSURE
2020-06-03
2020-06-04
7
TEDP07
EC
10001
4
ENDS
1
CARTRIDGE
INHALED
AD LIBITUM
PRODUCT EXPOSURE
2020-06-04
2020-06-05
8
TEDP07
EC
10001
5
PATCH
1
PATCH
TRANSDERMAL
LEG
LEFT
LOWER
PRODUCT EXPOSURE
2020-06-04
2020-06-05
9
TEDP07
EC
10001
6
ENDS
1
CARTRIDGE
INHALED
ONCE
PRODUCT EXPOSURE
2020-06-09T8:30
2020-06-09T8:40
10
TEDP07
EC
10001
7
PATCH
1
PATCH
TRANSDERMAL
LEG
RIGHT
LOWER
PRODUCT EXPOSURE
2020-06-10
2020-06-11
11
TEDP07
EC
10001
8
ENDS
1
CARTRIDGE
INHALED
AD LIBITUM
PRODUCT EXPOSURE
2020-06-10T12:40
2020-06-11
$warningHtml
Subject 10001 was randomized to the 5% pharmaceutical strength of the e- nicotine liquid, and subject 20001 was randomized to the active nicotine patch with a pharmaceutical strength of 14mg. The sponsor only represented the active product exposure for each subject in EX. .